Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Anticardiolipin antibodies in the sera of patients with diagnosed chronic fatigue syndrome.

Hokama Y, Campora CE, Hara C, Kuribayashi T, Le Huynh D, Yabusaki K.

J Clin Lab Anal. 2009;23(4):210-2. doi: 10.1002/jcla.20325.

PMID:
19623655
2.
4.

Elevated anticardiolipin antibodies in schizophrenic patients before and during neuroleptic medication.

Halacheva K, Dimova S, Tolev T, Dimov D, Nikolova M.

Psychiatry Res. 2009 Aug 30;169(1):51-5. doi: 10.1016/j.psychres.2008.05.011. Epub 2009 Jul 12.

PMID:
19596154
6.

Anticardiolipin antibodies and osteonecrosis of the femoral head.

Korompilias AV, Gilkeson GS, Ortel TL, Seaber AV, Urbaniak JR.

Clin Orthop Relat Res. 1997 Dec;(345):174-80.

PMID:
9418637
7.

Vascular dementia and anticardiolipin antibodies.

de Godoy JM, de Godoy MR, Cipulo JP, Tognola VA.

Med Sci Monit. 2005 Sep;11(9):CR430-3. Epub 2005 Aug 26.

PMID:
16127362
8.

Prevalence and clinical significance of anticardiolipin, anti-beta2-glycoprotein-1, and anti-heat shock protein-70 autoantibodies in sudden sensorineural hearing loss.

Gross M, Eliashar R, Ben-Yaakov A, Ulmansky R, Elidan J.

Audiol Neurootol. 2008;13(4):231-8. doi: 10.1159/000115432. Epub 2008 Feb 7.

PMID:
18259075
9.

Chagas disease and anticardiolipin antibodies in older adults.

Pereira de Godoy MR, Cação JC, Pereira de Godoy JM, Brandão AC, Silva Rossi Souza D.

Arch Gerontol Geriatr. 2005 Nov-Dec;41(3):235-8. Epub 2005 Jun 24.

PMID:
15979738
10.
11.

antiphospholipid antibodies and RA: presence of beta2GP1 independent aCL.

Bonnet C, Vergne P, Bertin P, Treves R, Jauberteau MO.

Ann Rheum Dis. 2001 Mar;60(3):303-4. No abstract available.

12.

Levels of anticardiolipin and anti-beta(2)-glycoprotein I antibodies in healthy newborn cord sera.

Nicaise-Roland P, Aurousseau MH, Delaval A, Grootenboer-Mignot S, Hurtado M, Carbillon L, Fain O, Uzan M, Lachassine E, Boffa MC, Chollet-Martin S.

Thromb Haemost. 2008 Jun;99(6):1124-6. doi: 10.1160/TH08-02-0074. No abstract available.

PMID:
18521522
13.

Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.

Seishima M, Mizutani Y, Shibuya Y, Arakawa C.

Dermatology. 2008;216(4):341-6. doi: 10.1159/000116723. Epub 2008 Feb 15.

PMID:
18277075
14.

Serum IgG and IgM anticardiolipin antibodies in neurological diseases.

Rombos A, Evangelopoulou-Katsiri E, Leventakou A, Voumvourakis K, Triantafyllou N, Papageorgiou C.

Acta Neurol Scand. 1990 Mar;81(3):243-5.

PMID:
2112819
17.

Immunoglobulin subclass abnormalities in patients with chronic fatigue syndrome.

Wakefield D, Lloyd A, Brockman A.

Pediatr Infect Dis J. 1990 Aug;9(8 Suppl):S50-3. No abstract available.

PMID:
2216608
18.

Anticardiolipin antibodies and antibodies to beta(2)-glycoprotein I in patients with Wegener's granulomatosis.

Lamprecht P, deGroot K, Schnabel A, Csernok E, Liedvogel B, Gross WL.

Rheumatology (Oxford). 2000 May;39(5):568-70. No abstract available.

PMID:
10852995
19.
20.

Immunoglobulin subclass levels in chronic fatigue syndrome.

Bennett AL, Fagioli LR, Schur PH, Schacterle RS, Komaroff AL.

J Clin Immunol. 1996 Nov;16(6):315-20.

PMID:
8946275

Supplemental Content

Support Center